Polymorphism in the TOMM40 Gene Modifies the Risk of Developing Sporadic Inclusion Body Myositis and the Age of Onset of Symptoms

Neuromuscular Disorders - United Kingdom
doi 10.1016/j.nmd.2013.09.008
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Sporadic Inclusion-Body Myositis and Hereditary Inclusion-Body Myopathies

Archives of Neurology
1998English

Pathomechanism and Prevalence of Sporadic Inclusion Body Myositis (sIBM)

Clinical Neurology
Neurology
2011English

CYLD Dysregulation in Pathogenesis of Sporadic Inclusion Body Myositis

Scientific Reports
Multidisciplinary
2019English

The Updated Retrospective Questionnaire Study of Sporadic Inclusion Body Myositis in Japan

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2019English

Anti-Nt5c1a Autoantibodies for the Diagnosis and Study of the Pathogenesis of Sporadic Inclusion Body Myositis

Clinical and Experimental Neuroimmunology
NeuroscienceNeurologyImmunologyMicrobiology
2017English

Theories of the Pathogenesis of Inclusion Body Myositis

Current Rheumatology Reports
Rheumatology
2010English

Clinical, Pathological, and Genetic Mutation Analysis of Sporadic Inclusion Body Myositis in Japanese People

Journal of Neurology
Neurology
2012English

An IGF-I Gene Polymorphism Modifies the Risk of Developing Persistent Microalbuminuria in Type 1 Diabetes

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2007English

Inclusion Body Myositis

Current Neurology and Neuroscience Reports
NeuroscienceNeurology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy